06/25/2014 - 1:09pm

Dr. Reddy's Labs on Wednesday announced that it has launched paricalcitol capsules in 1-mcg, 2-mcg and 4-mcg dosage strengths.

06/25/2014 - 11:05am

Pharmacists in Pennsylvania may soon be required to notify physicians prior to substituing a biologic medicine with a biosimilar medication following the passing of a bill by the Pennsylvania Senate, the Associated Press reported Tuesday.

06/23/2014 - 6:09pm

Lupin Pharmaceuticals last week announced the launch of ciprofloxacin oral suspension in 5 g/100 mL (250 mg/5 mL) and 10 g/100 mL (500 mg/5 mL) dosage strengths.

06/23/2014 - 1:05pm

The Food and Drug Administration announced that it has approved Sivextro (tedizolid phosphate), an antibacterial drug.

06/23/2014 - 10:51am

America’s biopharmaceutical research companies are developing 435 innovative new medicines to target 15 leading chronic conditions affecting the Medicare population, according to a new report released by the Pharmaceutical Research and Manufacturers of America last week.

06/19/2014 - 1:18pm

Novo Nordisk on Thursday announced the launch of Levemir FlexTouch (insulin detemir [rDNA origin] injection), a prefilled insulin delivery mechanism, providing a new way for diabetics to administer their insulin.

06/18/2014 - 1:59pm

Okinawa Life announced the introduction of Immunisol, an immune support supplement. The product has been shown to help increase natural killer cell activity, according to the company.

06/18/2014 - 1:57pm

Canada’s Federal Court ruled recently that the country’s Patented Medicine Prices Review Board — a federal tribunal that regulates pricing on branded medicines — could not extend price-control measures to cover generic drug companies, according to published reports.

06/17/2014 - 12:22pm

Novartis on Tuesday announced that it had submitted a biologic license application to the Food and Drug Administration for marketing approval for the use of Bexsero.